Analysts Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Price Target at $19.80

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has earned a consensus rating of “Buy” from the five research firms that are covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued ratings on the stock in […]

Related Keywords

Mexico ,Japan ,China ,United States ,Saudi Arabia ,Canada ,Piper Sandler ,Michael Shetzline ,Andrew Davis ,Craig Hallum ,Nasdaq ,Sg Americas Securities ,Exchange Traded Concepts ,Mackenzie Financial Corp ,Ironwood Pharmaceuticals Inc ,Ironwood Pharmaceuticals ,Ironwood Pharmaceuticals Stock Performance ,Gw Henssler Associates Ltd ,Xponance Inc ,News Ratings For Ironwood Pharmaceuticals Daily ,Hedge Funds Weigh In On Ironwood Pharmaceuticals ,Analyst Recommendations For Ironwood Pharmaceuticals ,Wells Fargo Company ,Get Free Report ,Marketbeat Ratings ,Traded Concepts ,Financial Corp ,Get Free ,Ironwood Pharmaceuticals Daily ,Nasdaq Irwd ,Irwd ,Medical ,46333x10 ,Ratings ,Consensus ,